Table 2. Characteristics of RR-TB/MDR-TB patients enrolled for treatment in 2012 and 2017.
| Baseline characteristics | 2012 Baseline | 2013 | 2014 | 2015 | 2016 | 2017 |
|---|---|---|---|---|---|---|
| n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | |
| Total (N) | 41 | 203 | 205 | 250 | 378 | 275 |
| Sex | ||||||
| Male | 26(63.4) | 126(62.1) | 131(63.9) | 168(67.2) | 247(65.3) | 172(62.6) |
| Female | 15(36.6) | 77(37.9) | 74(36.1) | 82(32.8) | 131(34.7) | 103(37.4) |
| Age (years) | ||||||
| <15 | 2(4.9) | 5(2.5) | 3(1.5) | 7(2.8) | 12(3.2) | 16(5.8) |
| 15–34 | 13(31.7) | 97(47.8) | 88 (42.9) | 132(52.8) | 180(47.6) | 122(44.4) |
| 35–54 | 24(58.5) | 91(44.8) | 101(49.3) | 96(38.4) | 153(40.5) | 106(38.5) |
| >54 | 2(4.9) | 10(4.9) | 13(6.3) | 14(5.6) | 33(8.7) | 30(10.9) |
| Missing age | 0(0.0) | 0(0.0) | 0(0.0) | 1(0.4) | 0(0.0) | 1(0.4) |
| Pulmonary | 39(95.1) | 200(98.5) | 201(98.1) | 248(99.2) | 373(98.7) | 269(97.8) |
| Extra-pulmonary | 2(4.9) | 3(1.5) | 4 (1.9) | 2(0.8) | 5(1.3) | 6(2.2) |
| HIV status | ||||||
| HIV-negative | 28(68.3) | 112(55.2) | 96(46.8) | 107(42.8) | 167(44.2) | 139(50.5) |
| HIV-positive | 13(31.7) | 91(44.8) | 109(53.2) | 143(57.2) | 211(55.8) | 136(49.5) |
N/n = Number of patients.
HIV—human immunodeficiency virus.